Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess

Acta Obstetricia et Gynecologica Scandinavica

Volumn 85, Issue 8, 2006, Pages 900-905

  Wiesli, Peter ^a,b   Zwimpfer, Cornelia ^a   Zapf, Jürgen ^a   Schmid, Christoph ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Kantonsspital Frauenfeld ^*  (Switzerland)

Author keywords

Acromegaly; Growth hormone; Pregnancy

Indexed keywords

ACID LABILE SUBUNIT PROTEIN; CORTICOSTERONE 21 ACETATE; GLUCOCORTICOID; GONADOTROPIN; OCTREOTIDE; PROTEIN SUBUNIT; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; THYROXINE; UNCLASSIFIED DRUG;

ACROMEGALY; ADULT; ANAMNESIS; ARTICLE; CASE REPORT; COMPARATIVE STUDY; DELIVERY; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FIRST TRIMESTER PREGNANCY; GALLSTONE; GROWTH HORMONE DEFICIENCY; HORMONAL REGULATION; HORMONE SUBSTITUTION; HUMAN; HYPOPHYSIS ADENOMA; HYPOPITUITARISM; IMMUNOBLOTTING; MALE INFERTILITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGOSPERMIA; ORAL GLUCOSE TOLERANCE TEST; PANCREATITIS; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS;

ACROMEGALY; ADULT; CARRIER PROTEINS; FEMALE; GLYCOPROTEINS; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 33746373989     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340600676532     Document Type: Article

References (26)

1. Scippo ML, Frankenne F, Hooghe-Peters EL, Igout A, Velkeniers B, Hennen G. Syncytiotrophoblastic localization of the human growth hormone variant mRNA in the placenta. Mol Cell Endocrinol. 1993;92:R7-13.
2. Gaufriez A, Frankenne F, Hennen G, Copinschi G. Regulation of maternal insulin-like growth factor I by placental growth hormone in pregnancy. Possible action of maternal IGF-I on fetal growth. Horm Res. 1994;42:62-5.
3. Frankenne F, Closset J, Gomez F, Scippo ML, Smal J, Hennen G. The physiology of growth hormones (GHs) in pregnant women and partial characterization of the placental GH variant. J Clin Endocrinol Metab. 1988;66:1171-80.
4. Eriksson L, Frankenne F, Eden S, Hennen G, Von Schoultz B. Growth hormone 24-h serum profiles during pregnancy - lack of pulsatility for the secretion of the placental variant. Br J Obstet Gynaecol. 1989;96:949-53.
5. Chellakooty M, Skibsted L, Skouby SO, Andersson AM, Petersen JH, Main KM, et al. Longitudinal study of serum placental GH in 455 normal pregnancies: correlation to gestational age, fetal gender, and weight. J Clin Endocrinol Metab. 2002;87:2734-9.
6. Boguszewski CL, Boguszewski MC, de Zegher F, Carlsson B, Carlsson LM. Growth hormone isoforms in newborns and postpartum women. Eur J Endocrinol. 2000;142:353-8.
7. Gaufriez A, Frankenne F, Englert Y, Golstein J, Cantraine F, Hennen G, et al. Placental growth hormone as a potential regulator of maternal IGF-I during human pregnancy. Am J Physiol. 1990;258:E1014-9.
8. Hossenlopp P, Segovia B, Lassarre C, Roghani M, Bredon M, Binoux M. Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150K complex during pregnancy. J Clin Endocrinol Metab. 1990;71:797-805.
9. Giudice LC, Farrell EM, Pham H, Lamson G, Rosenfeld RG. Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: effects of a pregnancy-associated serum protease activity. J Clin Endocrinol Metab. 1990;71:806-16.
10. Chellakooty M, Vangsgaard K, Larsen T, Scheike T, Falck-Larsen J, Legarth J, et al. A longitudinal study of intrauterine growth and the placental growth hormone (GH)-insulin-like growth factor I axis in maternal circulation: association between placental GH and fetal growth. J Clin Endocrinol Metab. 2004;89:384-91.
11. Dai J, Scott CD, Baxter RC. Regulation of the acid-labile subunit of the insulin-like growth factor complex in cultured rat hepatocytes. Endocrinology. 1994;135:1066-72.
12. Schmid C, Brandle M, Zwimpfer C, Zapf J, Wiesli P. Effect of thyroxine replacement on creatinine, insulin-like growth factor 1, acid-labile subunit, and vascular endothelial growth factor. Clin Chem. 2004;50:228-31.
13. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M. Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem. 1986;154:138-43.
14. Zapf J, Schmid C, Guler HP, Waldvogel M, Hauri C, Futo E, et al. Regulation of binding proteins for insulin-like growth factors (IGF) in humans. Increased expression of IGF binding protein 2 during IGF I treatment of healthy adults and in patients with extrapancreatic tumor hypoglycemia. J Clin Invest. 1990;86:952-61.
15. Schmid C, Ghirlanda-Keller C, Zapf J. Effects of IGF-I and - II, IGF binding protein-3 (IGFBP-3), and transforming growth factor-beta (TGF-beta) on growth and apoptosis of human osteosarcoma Saos-2/B-10 cells: lack of IGF-independent IGFBP-3 effects. Eur J Endocrinol. 2001;145:213-21.
16. Schmid C, Schlapfer I, Keller A, Waldvogel M, Froesch ER, Zapf J. Effects of insulin-like growth factor (IGF) binding proteins (BPs) -3 and -6 on DNA synthesis of rat osteoblasts: further evidence for a role of auto-/paracrine IGF I but not IGF II in stimulating osteoblast growth. Biochem Biophys Res Commun. 1995;212:242-8.
17. Schmid C, Keller C, Gosteli-Peter M, Zapf J. Mitogenic and antiapoptotic effects of insulin-like growth factor binding protein-6 in the human osteoblastic osteosarcoma cell line Saos-2/B-10. Biochem Biophys Res Commun. 1999;263: 786-9.
18. Curran AJ, Peacey SR, Shalet SM. Is maternal growth hormone essential for a normal pregnancy? Eur J Endocrinol. 1998;139:54-8.
19. Hall K, Enberg G, Hellem E, Lundin G, Ottosson-Seeberger A, Sara V, et al. Somatomedin levels in pregnancy: long-itudinal study in healthy subjects and patients with growth hormone deficiency. J Clin Endocrinol Metab. 1984;59:587-94.
20. Verhaeghe J, Bougoussa M, Van Herck E, de Zegher F, Hennen G, Igout A. Placental growth hormone and IGF-I in a pregnant woman with Pit-1 deficiency. Clin Endocrinol (Oxf). 2000;53:645-7.
21. Menashe Y, Sack J, Mashiach S. Spontaneous pregnancies in two women with Laron-type dwarfism: are growth hormone and circulating insulin-like growth factor mandatory for induction of ovulation? Hum Reprod. 1991;6:670-1.
22. Wiren L, Boguszewski CL, Johannsson G. Growth hormone (GH) replacement therapy in GH-deficient women during pregnancy. Clin Endocrinol (Oxf). 2002;57:235-9.
23. Herman-Bonert V, Seliverstov M, Melmed S. Pregnancy in acromegaly: successful therapeutic outcome. J Clin Endocrinol Metab. 1998;83:727-31.
24. Wilson DM, Bennett A, Adamson GD, Nagashima RJ, Liu F, DeNatale ML, et al. Somatomedins in pregnancy: a cross-sectional study of insulin-like growth factors I and II and somatomedin peptide content in normal human pregnancies. J Clin Endocrinol Metab. 1982;55:858-61.
25. Fuglsang J, Lauszus F, Orskov H, Ovesen P. Placental growth hormone during pregnancy in a growth hormone deficient woman with type 1 diabetes compared to a matching diabetic control group. Growth Horm IGF Res. 2004;14:66-70.
26. Whittaker PG, Stewart MO, Taylor A, Howell RJ, Lind T. Insulin-like growth factor 1 and its binding protein 1 during normal and diabetic pregnancies. Obstet Gynecol. 1990;76: 223-9.